TROP2-Expressing Solid Tumors
1 clinical trials · Condition
◉ Watch TROP2-Expressing Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors (NCT07589530) | Beijing Biotech | 2026-03-02 |
Track TROP2-Expressing Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.